{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:49:38Z","timestamp":1768366178406,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K16019"],"award-info":[{"award-number":["JP21K16019"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vasoplegia is a life-threatening intraoperative condition. Methylene blue (MB), a potent inhibitor of nitric oxide (NO) synthase and soluble guanylyl cyclase (sGC), can treat vasoplegia but may antagonize pulmonary arterial hypertension (PAH) drugs that enhance the NO-sGC-cyclic guanosine monophosphate (cGMP) pathway. Although reports on the use of MB for vasoplegia during liver transplantation (LT) have often been published, managing vasoplegia during LT in a patient with cardiopulmonary disease, including portopulmonary hypertension (PoPH) \u2013 a subgroup of PAH \u2013 with intracardiac shunt, is challenging and has not been reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      We report a 57-year-old woman with PoPH, on anti-PAH selexipag with concomitant atrial septal defect (ASD) undergoing deceased donor LT. After portal reperfusion, she developed refractory hypotension, in which mean arterial blood pressure (ABP) was less than 50\u00a0mmHg and the cardiac index (CI) was maintained at 5.0 L\u00b7min\n                      <jats:sup>\u22121<\/jats:sup>\n                      \u00b7m\n                      <jats:sup>\u22122<\/jats:sup>\n                      , despite high dose of vasopressin of 4 unit\u00b7h\n                      <jats:sup>\u22121<\/jats:sup>\n                      . Diagnosed with vasoplegia, she received 100\u00a0mg of MB. Mean ABP promptly improved from 45 to above 60\u00a0mmHg, systolic ABP from around 60 to above 95\u00a0mmHg, allowing immediate reduction of vasopressin to 0.5 unit\u00b7h\n                      <jats:sup>\u22121<\/jats:sup>\n                      . She was transferred to ICU with stable hemodynamics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MB can be lifesaving for intraoperative vasoplegia even in patients with PoPH on PAH drug therapy with an ASD, though potential drug interactions with anti-PAH drugs warrant caution.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12871-025-03544-7","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T06:34:45Z","timestamp":1765089285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Successful use of methylene blue for severe vasoplegia in a patient with partially-treated portopulmonary hypertension with atrial septal defect undergoing liver transplantation: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Taiga","family":"Ishihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaku","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuko","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanji","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Kariya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"issue":"1","key":"3544_CR1","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1213\/ANE.0000000000001045","volume":"122","author":"L Hosseinian","year":"2016","unstructured":"Hosseinian L, Weiner M, Levin MA, Fischer GW. Methylene blue: magic bullet for vasoplegia? Anesth Analg. 2016;122(1):194\u2013201.","journal-title":"Anesth Analg"},{"issue":"1","key":"3544_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13054-020-2743-8","volume":"24","author":"LW Busse","year":"2020","unstructured":"Busse LW, Barker N, Petersen C. Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options. Crit Care. 2020;24(1):36.","journal-title":"Crit Care"},{"issue":"2","key":"3544_CR3","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.chest.2017.12.021","volume":"154","author":"JC Jentzer","year":"2018","unstructured":"Jentzer JC, Vallabhajosyula S, Khanna AK, Chawla LS, Busse LW, Kashani KB. Management of refractory vasodilatory shock. Chest. 2018;154(2):416\u201326.","journal-title":"Chest"},{"issue":"9","key":"3544_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204364","volume":"13","author":"J Li","year":"2018","unstructured":"Li J, Chen X, Qi M, Li Y. Sentinel lymph node biopsy mapped with methylene blue dye alone in patients with breast cancer: a systematic review and meta-analysis. PLoS One. 2018;13(9):e0204364.","journal-title":"PLoS One"},{"key":"3544_CR5","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/hep.26745","volume":"59","author":"VI Machicao","year":"2014","unstructured":"Machicao VI, Balakrishnan M, Fallon MB. Pulmonary complications in chronic liver disease. Hepatology. 2014;59:1627\u201337.","journal-title":"Hepatology"},{"issue":"38","key":"3544_CR6","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618\u2013731.","journal-title":"Eur Heart J"},{"issue":"9419","key":"3544_CR7","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/S0140-6736(04)16107-2","volume":"363","author":"MM Hoeper","year":"2004","unstructured":"Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet. 2004;363(9419):1461\u20138.","journal-title":"Lancet"},{"issue":"25 Suppl","key":"3544_CR8","doi-asserted-by":"publisher","first-page":"D60","DOI":"10.1016\/j.jacc.2013.10.031","volume":"62","author":"N Gali\u00e8","year":"2013","unstructured":"Gali\u00e8 N, Corris PA, Frost A, et al. Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D60-72.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3544_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jhep.2020.02.021","volume":"73","author":"L Savale","year":"2020","unstructured":"Savale L, Guimas M, Ebstein N, et al. Portopulmonary hypertension in the current era of pulmonary hypertension management. J Hepatol. 2020;73(1):130\u20139.","journal-title":"J Hepatol"},{"issue":"3","key":"3544_CR10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.healun.2011.10.010","volume":"31","author":"M Patarroyo","year":"2012","unstructured":"Patarroyo M, Simbaqueba C, Shrestha K, et al. Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era. J Heart Lung Transplant. 2012;31(3):282\u20137.","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"3544_CR11","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jtcvs.2012.11.091","volume":"145","author":"J Hajj-Chahine","year":"2013","unstructured":"Hajj-Chahine J, Jayle C, Corbi P. Methylene blue in patients with severe pulmonary hypertension. J Thorac Cardiovasc Surg. 2013;145(3):898.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3544_CR12","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jtcvs.2012.12.063","volume":"145","author":"KJ Grubb","year":"2013","unstructured":"Grubb KJ, Kennedy JLW, Bergin JD, Groves DS, Kern JA. Reply to the editor. J Thorac Cardiovasc Surg. 2013;145:898\u20139.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3544_CR13","doi-asserted-by":"publisher","first-page":"H2376","DOI":"10.1152\/ajpheart.00654.2003","volume":"286","author":"K Uemura","year":"2004","unstructured":"Uemura K, Sugimachi M, Kawada T, et al. A novel framework of circulatory equilibrium. Am J Physiol Heart Circ Physiol. 2004;286:H2376-2385.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3544_CR14","unstructured":"Harvi by Harvi Dynamics. Harvi Dynamics. https:\/\/harvi.online\/. Accessed 02\/01\/2025."}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-025-03544-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-025-03544-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-025-03544-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:20:38Z","timestamp":1768342838000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12871-025-03544-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3544"],"URL":"https:\/\/doi.org\/10.1186\/s12871-025-03544-7","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,7]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}